HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Marui Selected Research

Malignant Fibrous Histiocytoma

9/2004Expression of transforming growth factor beta isoforms and their receptors in malignant fibrous histiocytoma of soft tissues.
9/2004Inhibitory effect of STI571 on cell proliferation of human malignant fibrous histiocytoma cell lines.
5/2004Expression of betacellulin, heparin-binding epidermal growth factor and epiregulin in human malignant fibrous histiocytoma.
3/2004Amphiregulin and epidermal growth factor receptor expression in human malignant fibrous histiocytoma of soft tissues.
1/2004Coexpression of hepatocyte growth factor and its receptor c-Met correlates with high MIB-1 proliferative index in malignant fibrous histiocytoma.
9/2003Immunohistochemical analysis of platelet-derived growth factor and its receptors in soft tissue malignant fibrous histiocytoma.
9/2003Expression of stem cell factor and lack of c-kit expression in malignant fibrous histiocytoma of soft tissues.
5/2003Expression of stem cell factor and c-kit in human malignant fibrous histiocytoma cell line (TNMY1).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Marui Research Topics

Disease

8Malignant Fibrous Histiocytoma
09/2004 - 05/2003
8Neoplasms (Cancer)
09/2004 - 01/2002
2Spinal Cord Diseases
02/2009 - 09/2006
2Osteosarcoma (Osteogenic Sarcoma)
02/2005 - 01/2002
2Sarcoma (Soft Tissue Sarcoma)
04/2003 - 11/2002
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2004
1Bursitis (Adhesive Capsulitis)
02/2003
1Hypertrophy
11/2002
1Fibroma (Fibromatosis)
07/2002

Drug/Important Bio-Agent (IBA)

3Stem Cell FactorIBA
02/2005 - 05/2003
2Protein Isoforms (Isoforms)IBA
09/2004 - 09/2003
2Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2004 - 11/2002
2Epidermal Growth Factor (EGF)IBA
05/2004 - 03/2004
2LigandsIBA
03/2004 - 05/2003
1Biological ProductsIBA
02/2005
1Transforming Growth Factor beta (TGF-beta)IBA
09/2004
1Imatinib Mesylate (Gleevec)FDA Link
09/2004
1Tyrosine Kinase InhibitorsIBA
09/2004
1EpiregulinIBA
05/2004
1Heparin (Liquaemin)FDA LinkGeneric
05/2004
1Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
05/2004
1BetacellulinIBA
05/2004
1AmphiregulinIBA
03/2004
1ErbB Receptors (EGF Receptor)IBA
03/2004
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2004
1platelet-derived growth factor AIBA
09/2003
1Platelet-Derived Growth FactorIBA
09/2003
1Platelet-Derived Growth Factor alpha ReceptorIBA
09/2003
1Messenger RNA (mRNA)IBA
05/2003
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2003
1Capsules (Microcapsules)IBA
07/2002

Therapy/Procedure

2Laminoplasty
02/2009 - 09/2006
2Replantation
11/2002 - 01/2002
1Decompression
02/2009
1Arthrodesis
02/2003
1Bone Transplantation (Bone Grafting)
11/2002
1Homologous Transplantation
11/2002
1Plastic Surgery Procedures
01/2002